News

Podcast

Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS

Author(s):

Pearl Steinzor

Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.

Nathan Walcker

Nathan Walcker

Florida Cancer Specialists & Research Institute's (FCS') Nathan Walcker, CEO, discusses some key strategic practices and initiatives in providing high quality community-based oncology care he has implemented at FCS.

He spoke with us at The American Journal of Managed Care®’s Institute for Value-Based Medicine® event held in Tampa, Florida, on August 10, 2023.

Listen above or through one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify


Related Videos
Elizabeth Jones, MD, FAAD
Barry Byrne, MD
Giulio Cossu, MD
Dr Toon Van Gorp
Frederick L. Locke, MD, Moffitt Cancer Center and Research Institute
Tom Belmont
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
AAD 2025 Recap
Dr Xin Hu
Brittany Craiglow, MD, FAAD
Related Content
A recent move by the Trump administration cancelled $400 million in funding, a lot of which was crucial for ongoing scientific and medical research. | image credit: lexiconimages - stock.adobe.com
March 18th 2025

Trump Administration Cancels Crucial Funding for Diabetes Prevention Program

Kyle Munz
Recent cuts to federal grants are set to have a widespread impact across numerous scientific and medical studies.
Managed Care Cast Logo
February 25th 2025

Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care

Pearl Steinzor Arthur L. Jenkins III, MD, FACS
On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Christopher L. Moertel, MD
March 18th 2025

How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas

Hayden E. Klein Christopher L. Moertel, MD
Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
managed care cast logo
February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD
On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Clinical research | Image Credit: © peshkova - stock.adobe.com
March 17th 2025

For Neuromuscular Disease Community, an Era of Opportunities and Threats

Christina Mattina
Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Annie Antar, MD, PhD; Lynae aArbes, PhD; Katrina Ortblad, ScD, MPH; Bridgette J. Picou, LVN, ACLPN; and Priscilla Tsondai, MD, MPH
March 17th 2025

Community, Connection, and Sharing the Science at CROI 2025

Maggie L. Shaw Annie Antar, MD, PhD Lynae Darbes, PhD Katrina Ortblad, ScD, MPH Bridgette J. Picou, LVN, ACLPN Priscilla Tsondai, MD, MPH
Experts share here what they take away from the Conference on Retroviruses and Opportunistic Infections (CROI) each year and why this meeting is so important in this space.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo